耐心资本如何赋能企业持续性创新?

How does Patient Capital Empower Sustained Innovation in Enterprises?

丁志国,宋易轩

2026 第 48 卷 第 05 期 页码 56-74

DOI: 10.16538/j.cnki.fem.20260129.401

PDF全文下载 HTML全文

摘要

持续性创新是企业保持竞争优势的重要条件,而耐心资本作为破解创新过程中资金供给与需求之间期限和风险错配问题的关键性制度安排,其赋能机制及经济效果则是一个亟待研究的问题。基于2013—2023年中国A股上市公司数据的实证研究发现,耐心资本确实能够有效赋能企业的持续性创新,且存在显著的累积优势效应;机制分析表明,耐心资本主要通过支撑型路径——资源效应和治理效应赋能持续性创新投入,且通过驱动型路径——知识宽度拓展效应和创新要素协同效应赋能持续性创新产出;异质性分析发现,耐心资本的赋能效应在高新技术企业、成熟期企业、技术密集型行业及东中部地区企业表现更为显著;经济后果显示,企业持续性创新能够为投资者创造明显超额回报,验证了资本的“耐心”更有时间“价值”。研究结论不仅能够为解决企业的持续性创新问题提供新思路,同时也能够为培育和壮大耐心资本提供理论依据和数据支持。

Sustained innovation is a critical factor for enterprises to maintain their competitive advantages. Patient capital is a key institutional arrangement to address the maturity and risk mismatch between capital supply and demand in the innovation process, and its empowering mechanism and economic effect remain an urgent issue to be studied. Based on data from China’s A-share listed companies from 2013 to 2023, this paper finds that patient capital can effectively facilitate sustained innovation with a significant cumulative advantage effect. Mechanism testing indicates that patient capital empowers sustained innovation input primarily through two supportive pathways—resource effect and governance effect, and empowers sustained innovation output through two driving pathways—knowledge breadth expansion effect and innovation factor synergy effect. Heterogeneity analysis indicates that the empowering effect of patient capital is more pronounced in high-tech enterprises, mature-stage enterprises, technology-intensive industries, and enterprises located in the eastern and central regions of China. Economic consequences show that sustained innovation can generate significant excess returns for investors, verifying that the “patience” of capital indeed yields greater “value” over time. This paper not only provides insights for resolving the issue of innovation sustainability among enterprises, but also offers a theoretical basis and empirical support for fostering and expanding patient capital.

参考文献

3 胡楠, 薛付婧, 王昊楠. 管理者短视主义影响企业长期投资吗?——基于文本分析和机器学习[J]. 管理世界, 2021, 37(5): 139-156,11. DOI:10.3969/j.issn.1002-5502.2021.05.012
7 兰竹虹, 曾晓, 辛莹莹. 产业竞争视角下税收征管对企业创新影响机制研究——基于“竞争效应”和“资源效应”[J]. 中国软科学, 2021, (2): 181-192. DOI:10.3969/j.issn.1002-9753.2021.02.017
8 冷建飞, 高云. 融资约束下企业社会责任信息披露质量与创新持续性——中小板企业数据分析[J]. 科技进步与对策, 2019, 36(11): 77-84. DOI:10.6049/kjjbydc.2018030110
28 杨国玉, 唐亮. 耐心资本对企业韧性的影响[J]. 财经科学, 2025, (3): 15-29.
34 钟宇翔, 吕怀立, 李婉丽. 管理层短视、会计稳健性与企业创新抑制[J]. 南开管理评论, 2017, 20(6): 163-177.
35 Antia M, Pantzalis C, Park J C. CEO decision horizon and firm performance: An empirical investigation[J]. Journal of Corporate Finance, 2010, 16(3): 288-301. DOI:10.1016/j.jcorpfin.2010.01.005
36 Cremers M, Pareek A. Patient capital outperformance: The investment skill of high active share managers who trade infrequently[J]. Journal of Financial Economics, 2016, 122(2): 288-306. DOI:10.1016/j.jfineco.2016.08.003
37 Deeg R, Hardie I, Maxfield S. What is patient capital, and where does it exist?[J]. Socio-Economic Review, 2016, 14(4): 615-625. DOI:10.1093/ser/mww030
38 Hall B H. The financing of research and development[J]. Oxford Review of Economic Policy, 2002, 18(1): 35-51. DOI:10.1093/oxrep/18.1.35
39 Hambrick D C, Mason P A. Upper echelons: The organization as a reflection of its top managers[J]. The Academy of Management Review, 1984, 9(2): 193-206. DOI:10.2307/258434
40 Klingler-Vidra R. When venture capital is patient capital: Seed funding as a source of patient capital for high-growth companies[J]. Socio-Economic Review, 2016, 14(4): 691-708. DOI:10.1093/ser/mww022
41 Kolasinski A C, Yang N. Managerial myopia and the mortgage meltdown[J]. Journal of Financial Economics, 2018, 128(3): 466-485. DOI:10.1016/j.jfineco.2017.03.010
42 Miller D, Friesen P H. A longitudinal study of the corporate life cycle[J]. Management Science, 1984, 30(10): 1161-1183. DOI:10.1287/mnsc.30.10.1161
43 Miller D J, Fern M J, Cardinal L B. The use of knowledge for technological innovation within diversified firms[J]. Academy of Management Journal, 2007, 50(2): 308-326.
44 Opper S, Burt R S. Social network and temporal myopia[J]. Academy of Management Journal, 2021, 64(3): 741-771. DOI:10.5465/amj.2019.1026
45 Tavassoli S, Karlsson C. Persistence of various types of innovation analyzed and explained[J]. Research Policy, 2015, 44(10): 1887-1901. DOI:10.1016/j.respol.2015.06.001
46 Triguero Á, Córcoles D. Understanding innovation: An analysis of persistence for Spanish manufacturing firms[J]. Research Policy, 2013, 42(2): 340-352. DOI:10.1016/j.respol.2012.08.003
47 Wu J F, Shanley M T. Knowledge stock, exploration, and innovation: Research on the united states electromedical device industry[J]. Journal of Business Research, 2009, 62(4): 474-483. DOI:10.1016/j.jbusres.2007.12.004